MMCM
PFE icon

Murphy & Mullick Capital Management’s Pfizer PFE Stock Holding History

Murphy & Mullick Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$511K Buy
18,214
+883
+5% +$23.5K 0.38% 63
2025
Q4 		$432K Buy
17,331
+3,849
+29% +$97.1K 0.31% 72
2025
Q3 		$333K Buy
13,482
+1,840
+16% +$45.4K 0.25% 88
2025
Q2 		$279K Buy
11,642
+2,028
+21% +$47.3K 0.23% 98
2025
Q1 		$244K Buy
9,614
+739
+8% +$19.3K 0.24% 103
2024
Q4 		$235K Buy
+8,875
New +$241K 0.22% 97

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Murphy & Mullick Capital Management's PFE Position: Q1 2026 in Review

Murphy & Mullick Capital Management increased its Pfizer (PFE) stake by 5.1% in Q1 2026, buying an estimated $23.5K and bringing the position to 18,214 shares worth $511K. The position accounts for 0.38% of the portfolio, ranked #63.

Murphy & Mullick Capital Management first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Murphy & Mullick Capital Management held 18,214 shares of Pfizer worth $511K as of Q1 2026.
  • Murphy & Mullick Capital Management bought 883 Pfizer shares in Q1 2026, an estimated $23.5K.
  • Pfizer made up 0.38% of Murphy & Mullick Capital Management's portfolio in Q1 2026, its #63 holding.
  • Murphy & Mullick Capital Management first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.